Lung Disease Treatment Pennsylvania

Many Pennsylvania residents suffer from debilitating lung diseases like chronic obstructive pulmonary disorder (COPD), pulmonary fibrosis and interstitial lung disease. While the leading cause is smoking, occupational hazards and air pollution are also causes of pulmonary disorders. Pennsylvania has high levels of air pollution, and is the fourth-largest coal mining state in the country. These risk factors increase resident’s odds for contracting a lung disease. Now you can learn more about Treating Lung Disease in PA.

Cellular Treatment Center

While cellular therapy isn’t a cure for lung disease, it has improved many patients’ quality of life. The Lung Institute uses cellular therapy to improve lung function. Everyone has cells in their bodies that act as our body’s system to promote healing. Cellular therapy specifically targets damaged areas and accelerates the healing process. The Lung Institute uses a minimally invasive procedure that extracts cells from fat tissue, blood or bone marrow, and reintroduces them back into the body, targeting the damaged lung tissue. Cellular therapy has significantly improved many patients’ lives by allowing them to breathe easier and do the things that they enjoy in life.

Cellular Treatment Center in Pennsylvania

Although Pittsburgh has some of the highest levels of air pollution in the United States, there is hope for those suffering from COPD. The Lung Institute is on its way.

If you or a loved one suffers from chronic lung disease, contact the Lung Institute to find out if cellular therapy can help get your life back within reach. Contact us by calling 888-745-6697 to see if you qualify.

*For more information, go to www.LungInstitute.com/Results.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.